[Autoimmune hepatitis in the pediatric age].

Area of Science:

• Pediatric hepatology
• Immunology
• Gastroenterology

Background:

• Autoimmune hepatitis (AIH) and sclerosing cholangitis are pediatric liver diseases driven by immune system damage.
• AIH is of unknown cause, marked by specific liver inflammation, high immunoglobulin levels, and autoantibodies.
• This condition predominantly affects young females and requires timely intervention.

Purpose of the Study:

• To outline the characteristics and management of autoimmune hepatitis in pediatric patients.
• To emphasize the importance of early diagnosis and treatment for improved outcomes.
• To highlight the role of immunosuppression and the potential need for liver transplantation.

Main Methods:

• Review of clinical presentation and diagnostic markers of autoimmune hepatitis in children.
• Analysis of treatment responses to immunosuppressive therapy.
• Evaluation of factors leading to liver failure and the indication for liver transplantation.

Main Results:

• Autoimmune hepatitis presents with interface hepatitis, hypergammaglobulinemia, and autoantibodies.
• Pediatric patients typically respond well to immunosuppressive treatment.
• Treatment non-response or non-adherence can lead to end-stage liver disease.

Conclusions:

• Early initiation of immunosuppression is vital for managing pediatric autoimmune hepatitis, improving remission rates, and ensuring long-term survival.
• Liver transplantation remains a critical option for patients with refractory disease or acute liver failure.